• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

失调的 microRNAs 在阿尔茨海默病的进展和发病机制中的作用。

Dysregulated miRNAs in Progression and Pathogenesis of Alzheimer's Disease.

机构信息

Department of Zoology, School of Biological Sciences, Central University of Punjab, Ghudda 151 401, Bathinda, Punjab, India.

Department of Biochemistry and Molecular Biology, Guru Nanak Dev University, Amritsar, 143101, Punjab, India.

出版信息

Mol Neurobiol. 2022 Oct;59(10):6107-6124. doi: 10.1007/s12035-022-02950-z. Epub 2022 Jul 22.

DOI:10.1007/s12035-022-02950-z
PMID:35867206
Abstract

Alzheimer's disease (AD) is a progressive degeneration of neurons due to the accumulation of amyloid-β peptide (Aβ) and hyper-phosphorylation of tau protein in the neuronal milieu leading to increased oxidative stress and apoptosis. Numerous factors contribute towards the progression of AD, including miRNA, which are 22-24 nucleotides long sequence which acts as critical regulators of cellular processes by binding to 3' UTR of mRNA, regulating its expression post-transcriptionally. This review aims to determine the miRNA with the most significant dysregulation in the brain and cerebrospinal fluid (CSF) of human patients. A systemized inclusion/exclusion criterion has been utilized based on selected keywords followed by screening of those articles to conclude a list of 8 highly dysregulated miRNAs based on the fold change of AD vs control patients, which could be used in clinical testing as these miRNAs play central role in the pathophysiology of AD. Furthermore, a network study of highly dysregulated miRNA estimated the association of these miRNA in the mediation of Aβ generation and aggregation, inhibition of autophagy, reduction of Aβ clearance, microglial and astrocytic activation, neuro-inflammation, tau hyper-phosphorylation, and synaptic loss.

摘要

阿尔茨海默病(AD)是由于神经元环境中淀粉样β肽(Aβ)的积累和 tau 蛋白的过度磷酸化导致神经元退化,导致氧化应激和细胞凋亡增加。许多因素导致 AD 的进展,包括 miRNA,其长度为 22-24 个核苷酸,通过与 mRNA 的 3'UTR 结合,作为细胞过程的关键调节剂,在转录后调节其表达。本综述旨在确定大脑和人类患者脑脊液(CSF)中失调最严重的 miRNA。根据选定的关键词利用系统的纳入/排除标准,然后筛选这些文章,得出了 8 个高度失调的 miRNA 列表,这些 miRNA 的失调倍数与 AD 患者与对照患者相比,可用于临床测试,因为这些 miRNA 在 AD 的病理生理学中发挥核心作用。此外,对高度失调 miRNA 的网络研究估计了这些 miRNA 在介导 Aβ生成和聚集、抑制自噬、减少 Aβ清除、小胶质细胞和星形胶质细胞激活、神经炎症、tau 过度磷酸化和突触丢失中的作用。

相似文献

1
Dysregulated miRNAs in Progression and Pathogenesis of Alzheimer's Disease.失调的 microRNAs 在阿尔茨海默病的进展和发病机制中的作用。
Mol Neurobiol. 2022 Oct;59(10):6107-6124. doi: 10.1007/s12035-022-02950-z. Epub 2022 Jul 22.
2
MicroRNA in Alzheimer's disease revisited: implications for major neuropathological mechanisms.阿尔茨海默病中的 microRNA 再探:对主要神经病理学机制的影响。
Rev Neurosci. 2018 Feb 23;29(2):161-182. doi: 10.1515/revneuro-2017-0042.
3
Amyloid Beta and Phosphorylated Tau-Induced Defective Autophagy and Mitophagy in Alzheimer's Disease.淀粉样β和磷酸化 tau 诱导的阿尔茨海默病中的自噬和 mitophagy 缺陷。
Cells. 2019 May 22;8(5):488. doi: 10.3390/cells8050488.
4
MicroRNA Dysregulation in Alzheimer's Disease.阿尔茨海默病中的 microRNA 失调。
CNS Neurol Disord Drug Targets. 2017;16(9):1000-1009. doi: 10.2174/1871527316666170807142311.
5
Key Peptides and Proteins in Alzheimer's Disease.阿尔茨海默病相关的关键肽和蛋白
Curr Protein Pept Sci. 2019;20(6):577-599. doi: 10.2174/1389203720666190103123434.
6
Synaptic Loss, ER Stress and Neuro-Inflammation Emerge Late in the Lateral Temporal Cortex and Associate with Progressive Tau Pathology in Alzheimer's Disease.突触丢失、内质网应激和神经炎症在外侧颞叶皮层中晚期出现,并与阿尔茨海默病中的进行性 Tau 病理学相关。
Mol Neurobiol. 2020 Aug;57(8):3258-3272. doi: 10.1007/s12035-020-01950-1. Epub 2020 Jun 8.
7
Death-associated protein kinase 1 mediates Aβ42 aggregation-induced neuronal apoptosis and tau dysregulation in Alzheimer's disease.死亡相关蛋白激酶 1 介导 Aβ42 聚集诱导的阿尔茨海默病神经元凋亡和 tau 失调。
Int J Biol Sci. 2022 Jan 1;18(2):693-706. doi: 10.7150/ijbs.66760. eCollection 2022.
8
Understanding the multifaceted role of miRNAs in Alzheimer's disease pathology.理解 miRNA 在阿尔茨海默病病理中的多方面作用。
Metab Brain Dis. 2024 Jan;39(1):217-237. doi: 10.1007/s11011-023-01265-9. Epub 2023 Jul 28.
9
Linking deregulation of non-coding RNA to the core pathophysiology of Alzheimer's disease: An integrative review.将非编码RNA失调与阿尔茨海默病的核心病理生理学联系起来:一项综合综述。
Prog Neurobiol. 2017 Sep;156:1-68. doi: 10.1016/j.pneurobio.2017.03.004. Epub 2017 Mar 18.
10
Primary Hypothyroidism and Alzheimer's Disease: A Tale of Two.原发性甲状腺功能减退症与阿尔茨海默病:二者的关系
Cell Mol Neurobiol. 2023 Oct;43(7):3405-3416. doi: 10.1007/s10571-023-01392-y. Epub 2023 Aug 4.

引用本文的文献

1
The intersection between circulatory microRNAs and biomarkers of neurodegeneration.循环微RNA与神经退行性变生物标志物之间的交叉点。
Alzheimers Res Ther. 2025 Jul 30;17(1):179. doi: 10.1186/s13195-025-01831-6.
2
Posterior cingulate cortex microRNA dysregulation differentiates cognitive resilience, mild cognitive impairment, and Alzheimer's disease.后扣带回皮质微小RNA失调可区分认知恢复力、轻度认知障碍和阿尔茨海默病。
Alzheimers Dement. 2025 Feb;21(2):e70019. doi: 10.1002/alz.70019.
3
miR-92a-3p and miR-320a are Upregulated in Plasma Neuron-Derived Extracellular Vesicles of Patients with Frontotemporal Dementia.

本文引用的文献

1
Regulation of microRNAs in Alzheimer´s disease, type 2 diabetes, and aerobic exercise training.阿尔茨海默病、2 型糖尿病和有氧运动训练中 microRNAs 的调控。
Metab Brain Dis. 2022 Mar;37(3):559-580. doi: 10.1007/s11011-022-00903-y. Epub 2022 Jan 25.
2
The promise of microRNA-based therapies in Alzheimer's disease: challenges and perspectives.基于 microRNA 的疗法在阿尔茨海默病中的应用前景:挑战与展望。
Mol Neurodegener. 2021 Nov 6;16(1):76. doi: 10.1186/s13024-021-00496-7.
3
A Review of miRNAs as Biomarkers and Effect of Dietary Modulation in Obesity Associated Cognitive Decline and Neurodegenerative Disorders.
miR-92a-3p和miR-320a在额颞叶痴呆患者血浆神经元来源的细胞外囊泡中上调。
Mol Neurobiol. 2025 Feb;62(2):2573-2586. doi: 10.1007/s12035-024-04386-z. Epub 2024 Aug 14.
4
Correlation of brain tissue volume loss with inflammatory biomarkers IL1β, P-tau, T-tau, and NLPR3 in the aging cognitively impaired population.衰老认知受损人群中脑组织体积损失与炎症生物标志物白细胞介素-1β(IL1β)、磷酸化tau蛋白(P-tau)、总tau蛋白(T-tau)和NLR家族pyrin结构域包含3蛋白(NLPR3)的相关性。
Front Aging Neurosci. 2024 Jul 23;16:1388654. doi: 10.3389/fnagi.2024.1388654. eCollection 2024.
5
Epigenetic Mechanisms of Aluminum-Induced Neurotoxicity and Alzheimer's Disease: A Focus on Non-Coding RNAs.铝诱导神经毒性和阿尔茨海默病的表观遗传机制:聚焦于非编码 RNA。
Neurochem Res. 2024 Nov;49(11):2988-3005. doi: 10.1007/s11064-024-04214-9. Epub 2024 Jul 27.
6
The role of microRNAs in understanding sex-based differences in Alzheimer's disease.microRNAs 在理解阿尔茨海默病性别差异中的作用。
Biol Sex Differ. 2024 Jan 31;15(1):13. doi: 10.1186/s13293-024-00588-1.
7
miR-129-5p as a biomarker for pathology and cognitive decline in Alzheimer's disease.miR-129-5p 作为阿尔茨海默病病理和认知衰退的生物标志物。
Alzheimers Res Ther. 2024 Jan 9;16(1):5. doi: 10.1186/s13195-023-01366-8.
8
miR-129-5p as a biomarker for pathology and cognitive decline in Alzheimer's disease.miR-129-5p作为阿尔茨海默病病理学和认知衰退的生物标志物
Res Sq. 2023 Nov 1:rs.3.rs-3501125. doi: 10.21203/rs.3.rs-3501125/v1.
9
Modulation of microRNAs through Lifestyle Changes in Alzheimer's Disease.通过生活方式改变调节阿尔茨海默病中的 microRNAs。
Nutrients. 2023 Aug 23;15(17):3688. doi: 10.3390/nu15173688.
10
Understanding the multifaceted role of miRNAs in Alzheimer's disease pathology.理解 miRNA 在阿尔茨海默病病理中的多方面作用。
Metab Brain Dis. 2024 Jan;39(1):217-237. doi: 10.1007/s11011-023-01265-9. Epub 2023 Jul 28.
作为生物标志物的微小RNA以及饮食调节对肥胖相关认知衰退和神经退行性疾病的影响综述
Front Mol Neurosci. 2021 Oct 7;14:756499. doi: 10.3389/fnmol.2021.756499. eCollection 2021.
4
Multifaceted Alzheimer's Disease: Building a Roadmap for Advancement of Novel Therapies.多层面阿尔茨海默病:为新型疗法的推进构建路线图。
Neurochem Res. 2021 Nov;46(11):2832-2851. doi: 10.1007/s11064-021-03415-w. Epub 2021 Aug 6.
5
MicroRNA-138 suppresses glioblastoma proliferation through downregulation of CD44.微小 RNA-138 通过下调 CD44 抑制脑胶质瘤增殖。
Sci Rep. 2021 Apr 28;11(1):9219. doi: 10.1038/s41598-021-88615-8.
6
Enrichment of the erythrocyte miR-451a in brain extracellular vesicles following impairment of the blood-brain barrier.血脑屏障损伤后红细胞 miR-451a 在脑细胞外囊泡中的富集。
Neurosci Lett. 2021 Apr 23;751:135829. doi: 10.1016/j.neulet.2021.135829. Epub 2021 Mar 13.
7
Critical roles of sphingosine kinase 1 in the regulation of neuroinflammation and neuronal injury after spinal cord injury.鞘氨醇激酶 1 在脊髓损伤后神经炎症和神经元损伤中的关键作用。
J Neuroinflammation. 2021 Feb 18;18(1):50. doi: 10.1186/s12974-021-02092-4.
8
Loss of DEK Expression Induces Alzheimer's Disease Phenotypes in Differentiated SH-SY5Y Cells.DEK表达缺失在分化的SH-SY5Y细胞中诱导阿尔茨海默病表型。
Front Mol Neurosci. 2020 Nov 16;13:594319. doi: 10.3389/fnmol.2020.594319. eCollection 2020.
9
MicroRNAs in Alzheimer's Disease: Function and Potential Applications as Diagnostic Biomarkers.阿尔茨海默病中的微小RNA:功能及作为诊断生物标志物的潜在应用
Front Mol Neurosci. 2020 Aug 21;13:160. doi: 10.3389/fnmol.2020.00160. eCollection 2020.
10
Obesity and Insulin Resistance: Associations with Chronic Inflammation, Genetic and Epigenetic Factors.肥胖与胰岛素抵抗:与慢性炎症、遗传和表观遗传因素的关联。
Curr Med Chem. 2021;28(4):800-826. doi: 10.2174/0929867327666200824112056.